Skip to main content
. 2023 Aug 2;56(4):626–634. doi: 10.1007/s11239-023-02855-1

Fig. 1.

Fig. 1

Geographic Variation of Baseline CHA2DS2-VASc Score (A) and Follow-up Stroke/SE Incidence Rate (B) Among Medicare Patients with NVAF from 2013–2016. Baseline CHA2DS2-VASc score and follow-up stroke/SE incidence rates were measured among all patients with NVAF by 3-digit zip code (N = 2,828,416). Incidence rates were measured per 100 person-years. Regions with higher risk scores were also the areas of higher stroke/SE incidence